Showing results (311-320 of 548) with videos related to
Sort By:
Pageof 55
Therapeutic Advances in Psychopharmacology|August 29, 2013
A review of modafinil and armodafinil as add-on therapy in antipsychotic-treated patients with schizophreniaLaura Christina Wittkampf, Johannes Arends, Leo Timmerman, et al.Therapeutic Advances in Psychopharmacology|August 29, 2013
The effects of quercetin supplementation on cognitive functioning in a community sample: a randomized, placebo-controlled trialJoshua J Broman-Fulks, Will H Canu, Krystal L Trout, et al.Therapeutic Advances in Psychopharmacology|August 29, 2013
Transdermal patches: the emerging mode of drug delivery system in psychiatryMiriam Isaac, Carl HolveyTherapeutic Advances in Psychopharmacology|November 1, 2014
Asenapine augmentation and treatment-resistant schizophrenia in the high-secure hospital settingE Naomi Smith, Vijay Durge, Samrat Sengupta, et al.Therapeutic Advances in Psychopharmacology|January 4, 2020
Physical health monitoring after rapid tranquillisation: clinical practice in UK mental health servicesCarol Paton, Clive E Adams, Stephen Dye, et al.Therapeutic Advances in Psychopharmacology|September 14, 2020
Dopamine-receptor blocking agent-associated akathisia: a summary of current understanding and proposal for a rational approach to treatmentShaina Musco, Vivian McAllister, Ian CaudleTherapeutic Advances in Psychopharmacology|September 14, 2020
Usefulness of vortioxetine noted in depression secondary to hypoxic brain injury and residual cognitive deficitsSyeda Maheen Ahsan, Syed Daniyal Ahsan, Osman Khalid, et al.Therapeutic Advances in Psychopharmacology|October 6, 2025
Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trialSally Meikle, Olivia Carter, Paul Liknaitzky, et al.Therapeutic Advances in Psychopharmacology|October 20, 2025
Treating job-related stress with psychedelic group therapy: a case series on group ketamine-assisted psychotherapy for healthcare workers and first respondersLuke Flynn, Martin Krsak, Mary Rondeau, et al.Therapeutic Advances in Psychopharmacology|October 22, 2025
Real-world examination of the rates of long-acting injectable attrition in a cohort of early psychosis patients after discharge from an early intervention service for psychosisCandice E Crocker, Thomas Hastings, Marc-Andre Roy, et al.Pageof 55